Align Technology (ALGN) Stock Valuation After Earnings Beat And Renewed Investor Optimism
Align Technology (ALGN) Stock Valuation After Earnings Beat And Renewed Investor Optimism
Publish Date: 2026-06-14 04:21:00
Source Domain: simplywall.st
Align Technology (ALGN) has jumped back onto investors’ radar after quarterly results beat analyst expectations on both revenue and earnings per share, with bullish ratings and supportive technical signals reinforcing the shift in sentiment.
See our latest analysis for Align Technology.
At a share price of $174.84, Align’s recent 7 day share price return of 4.23% and 30 day share price return of 11.19% suggest momentum is building again, even though the 1 year total shareholder return is slightly down and longer term total shareholder returns over 3 and 5 years remain sharply weaker.
If Align’s rebound has your attention, this is a good moment to scan the broader healthcare AI opportunity set with our 40 healthcare AI stocks
With Align trading at a discount to both one valuation estimate and the average analyst price target, yet carrying a weak 3 and 5 year shareholder return record, investors face a key question: Is there genuine value here, or is the market already pricing in whatever growth comes next?
Most Popular Narrative: 13.1% Overvalued
According to the most widely followed narrative, Align’s fair value is set at $154.62, which sits below the last close of $174.84 and presents the recent rebound in a more cautious light.
Today, Align operates in a different environment. Inflation, discretionary spending pressure, and rising competition are testing whether premium orthodontics can sustain growth without sacrificing margins.
Read the complete narrative.
The core narrative focuses on Align’s ability to keep margins supported while balancing premium pricing, disciplined investment, and measured growth in new markets. Investors may wish to examine which revenue and earnings assumptions sit behind that view, and how they translate into that specific fair value, before weighing this rebound against the longer term track record.
Result: Fair Value of $154.62 (OVERVALUED)
Have a read of the narrative in full and understand what’s behind the…